INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease accompanied by several common symptoms including erythema, eczema, and pruritus [1] . In AD, skin becomes extremely itchy followed by severe scratching behavior that induces the production of proinflammatory cytokines. This in turn activates immune cells and initiates inflammatory cycle of AD that accompanied by erythema, keratosis and its scaling. All these symptoms are the consequence of an imbalanced immune response to various allergens [2] . Another defining characteristic of the atopic immune system is the capacity to generate elevated IgE antibodies and type 2 helper T cells (T H 2) are critical for IgE synthesis. T H 2 cells predominantly produce interleukin (IL)-4, IL-5, IL-10, and IL-13, and these cytokines are associated with specific function of immune cells in AD. For example, they act as excellent helpers for B cell activation, particularly antibody responses [3] [4] [5] . IL-4, mainly produced by activated T cell, plays a prominent role in immune responses. It also works as the most important determinant of IgE isotype switching in B cell, which in turn elicits allergic immune response, and induces differentiation of naïve CD4 T cells into T H 2 cells [6, 7] . Expression of IL-4 appears to be regulated at the transcriptional level and the nuclear factor of activated T cells (NFAT) has been suggested as a transcriptional activator of cytokine genes [8, 9] .
Red ginseng (Panax ginseng C.A. Meyer Radix Rubra) has been most widely used for a long time to enhance immune function as well as stamina, and it has been reported that ginseng has pharmacological effects on the cardiovascular, endocrine, and central nervous systems [10] . Among the components of ginseng, Allergies are immediate hypersensitive responses to antigens and interleukin (IL)-4 is involved in the initiation and development of allergic responses. Rb 1 has been known to have a variety of biological activities including anti-inflammatory activity, but the effect of Rb 1 on allergic responses is not known yet. The present study was undertaken to examine whether Rb 1 has an inhibitory effect on allergic response in mouse model. In allergic mouse model, our results showed that topical application of Rb 1 on atopic dermatitis (AD)-like skin lesions improved skin condition and inhibited starching behaviors. In addition, Rb 1 application not only suppressed mRNA expression of IL-4 and IL-10, but also prevented the nuclear factor of activated T cells 1 transcription. Moreover, Rb 1 application suppressed IL-4's secretion. Taken together, these results suggest that Rb 1 has a potent inhibitory effect in AD-related T cell cytokine production and may be a candidate for therapeutic agent in allergy. 3 , and Rh 2 are the most commonly studied ginsenosides in research and hundreds papers have been reported that ginsenosides show various biological activities including anti-inflammatory, anti-allergic, and anti-tumor activities [11] [12] [13] . However, anti-atopic effect of Rb 1 in vivo has not been thoroughly studied. The aim of the present study therefore was to determine whether topical application of Rb 1 has inhibitory effects on ADlike skin lesions in animal model.
Inhibitory Effects of

Keywords
MATERIALS AND METHODS
Animals and reagents
Six-week-old male BALB/c mice were obtained from the Daehan Biolink Co. (Eumseong, Korea) and housed with free access to food as well as water ad libitum. During the experimental period, All animals were maintained at a temperature of 23±1°C, a humidity of 55±5% with 10 to 18 circulation/hour under 12 hours light/ dark cycle. The animals were randomly divided into five groups with 5 mice. Group 1, normal control group; group 2, vehicle-treated group; group 3, dexamethasonetreated group; and group 4 and 5, Rb 1 -treated groups. 
Induction and treatment of atopic dermatitis-like skin lesions in mice
1-chloro-2,4-dinitrobenzene (DNCB) was used as an inducer of AD. Induction of AD-like skin lesions was performed according to the method of Kim et al. [14] with modification. Briefly, 1% of DNCB was freshly dissolved in aceton:olive oil (4:1) and topically applied on the shaved area of dorsal surface twice for a week, and 0.2% of DNCB was then applied in a same way (four times in total). After inducing AD-like skin lesions, skin lesions were treated with Dulbecco's phosphate buffered saline vehicle, dexamethasone (positive control), or Rb 1 (50 and 100 μg/mL) every other day (four times in total). The concentrations of Rb 1 were selected based on previous reports [15] . To compare the improvement of skin condition by treatment with each compound, pictures were taken before and after the treatment.
Measurement of scratching behavior frequency
Scratching behavior was observed after completion of all treatments. In brief, the mice were placed into cages and the number of scratching behaviors was counted for 10 minutes. Measurement was repeated for five times (50 minutes in total). The scratching behavior was defined as the movement with hind paws in this experiment.
Determination of interleukin-4 secretion
The spleens were aseptically removed and total splenocytes were prepared. Splenocytes (5×10 5 cells/well) were plated at 96-well plates and incubated for 24 hours in RPMI 1640 medium (GIBCO, Grand Island, NY, USA) containing 10% of FBS (Hyclone, Logan, UT, USA), penicillin (100 U/mL), and streptomycin (100 μg/ mL) at 37°C in a 5% CO 2 humidified incubator. Culture supernatants were collected and the amount of secreted IL-4 was measured using enzyme-linked immunoassay kit purchased from Biolegend, Inc. (San Diego, CA, USA).
Measurement of serum IgE level
Blood samples were collected from the inferior vena cava after finishing treatment and serum was separated. The serum concentration of IgE was measured by enzyme-linked immunoassay kit purchased from Biolegend, Inc.
RT-PCR analysis of gene expression
The expression of mRNA transcripts of IL-4, IL-10 and NFAT was determined by reverse transcriptasepolymerase chain reaction. Total RNA was extracted from splenocytes using the Trizol (Invitrogen, Carlsbad, CA, USA) reagent and processed to cDNA with RevertAid (Fermentas, Vilnius, Lithuania). Solgent TM EF-Taq DNA Polymerase kit (Solgent Co., Daejeon, Korea) was used for PCR analysis and cDNA was amplified using primers as shown in Table 1 .
RESULTS
Effect of Rb 1 on atopic dermatitis-like skin lesions
AD-like skin lesions were induced in BALB/c mice by topical application of DNCB compared to untreated group ( Fig. 2A) . After the first application of DNCB, erythema began to appear on the back followed by eczema and keratosis with final application (Fig. 2B-E ). In contrast, treatment of AD-like skin lesions with Rb 1 resulted in improved skin condition (Fig. 2I and 2J ) as compared to the DNCB-treated group (Fig. 2G) . We also examined the inhibitory effect of dexamethasone, a well-known anti-inflammatory and immunosuppressant. As shown in Fig. 2B , dexamethasone significantly reduced DNCBinduced AD-like skin lesions. Based on these findings, Rb 1 may have activities similar to dexamethasone.
Effect of Rb 1 on scratching behavior frequency
To investigate the antiatopic effect of Rb 1 , we examined the effect Rb 1 on scratching behavior, a typical clinical symptom of AD. DNCB application caused a substantial increase in the frequency of scratching behavior. However, Rb 1 treatment significantly suppressed DNCB-mediated scratching behavior (Fig. 3) , although its inhibitory effect was less significant than dexamethasone, a type of steroid drug used to treat many inflammatory diseases.
Effect of Rb 1 on interleukin-4 secretion
Overexpression of IL-4 is associated with allergic response. To further investigate the mechanism of action of Rb 1 , we examined the effect Rb 1 on IL-4 secretion. As shown in Fig. 4 , DNCB-induced AD mice showed much higher level of secreted IL-4 than that of control mice, NFAT, nuclear factor of activated T cells. while Rb 1 treatment suppressed secretion of IL-4 and Rb 1 appears to be more effective than dexamethasone on suppression of IL-4 secretion.
Effect of Rb 1 on mRNA levels of cytokines and NFAT1
To determine whether Rb 1 might be involved in cytokine gene regulation, the levels of IL-4 and IL-10 mRNA expression on splenocytes were examined by RT-PCR analysis. DNCB significantly induced mRNA levels of both IL-4 and IL-10. When DNCB-induced AD mice were treated with 100 μg/mL of Rb 1 four times, Rb 1 suppressed DNCB-induced mRNA levels of IL-4 as well as IL-10 (Fig. 5A) . The effect of Rb 1 on mRNA level of NFAT1, which is known to induce various cytokine genes including IL-4, was also examined. Consistent with mRNA levels of cytokines, Rb 1 treatment resulted in decrease of NFAT1 expression (Fig. 5 B) .
Effect of Rb 1 on serum IgE level
High level of IgE in the blood is a clear indicator of AD. Therefore, we examined whether Rb 1 can suppress serum IgE in AD mice. Although dexamethasone decreased DNCB-induced IgE in serum, Rb 1 treatment did not suppress (Fig. 6) .
DISCUSSION
In the present study, we examined the effect of Rb 1 on AD-like skin lesions in mice. Skin sensitivity and inflammation induced by DNCB have been known to be characterized by raised IgE and cytokines such as IL-4 and IL-10 [14, 16] . The results of this study demonstrate that topically applied ginsenoside Rb 1 exerts beneficial effects in mouse model of AD.
In atopic dermatitis, skin lesions were characterized by infiltration of IL-4 producing CD4 + T cells, indicating that IL-4 is likely to play a major role in AD since it me- Fig. 3 . Inhibitory effect of Rb 1 on 1-chloro-2,4-dinitrobenzene (DNCB)-induced scratching behaviors. Scratching behavior was observed after completion of all treatments. In brief, the number of scratching behaviors was counted for 10 minutes. Measurement was repeated for five times (50 minutes in total). Dex, dexamethasone.
* Significantly different from DNCB-treated group (p<0.05). diates Ig isotype switching from IgM to IgE [6, 7] . In addition, IL-10 plays an important role in the T H 2 response in a murine model of allergic dermatitis [17] . It has been also known that the upregulation of total serum IgE is a hallmark of AD [18] . Our data showed that the expression of IL-4 and IL-10 increased in the splenocytes from the control mice developing skin lesions was suppressed by Rb 1 treatment. However, although the application of Rb 1 significantly reduced the severities of AD-like skin lesions induced by DNCB, it did not inhibit total serum IgE levels. For many years there has been an argument for the contribution of IgE-mediated hypersensitivity reactions in the pathogenesis of AD [19] , because in some chronic AD skin lesions the development of AD appears to be independent of plasma IgE levels. Moreover, it has recently been suggested that increased IgE production and subsequent IgE-mediated hypersensitivity reactions may not contribute to the development of the AD-like skin lesions observed in NC/Nga mouse model [20] . Therefore, the results of this study do not support the notion that IgE plays a role in modulating AD-like lesions induced by DNCB and might provide an extended scope to the prevailing concept of IgE-independent mechanism underlying the pathobiology of AD.
T H 2 cells produce IL-4, IL-5, and IL-10, and are involved in humoral immunity and the allergic response. Our results demonstrated that Rb 1 inhibited DNCBinduced transcript levels for the cytokines. This suggests that Rb 1 may inhibit the expression of cytokines by interfering with the transcription of their respective genes. It may inhibit either the initiation of transcription or the stability of the mRNAs encoding these molecules. It has been also shown that activation of transcription factor NFAT is required for the transcriptional activation of cytokines [8, 9] , suggesting that NFAT appears to play a pivotal role in IL-4 and IL-10 gene activation. Therefore, the decreased expression of IL-4 and IL-10 prompted us to examine the effect of Rb 1 on NFAT implicated in the regulation of a variety of genes participating in immune responses, including genes encoding IL-4 and IL-10. The present data showed that Rb 1 inhibited DNCBinduced NFAT activation. However, our results do not eliminate the possible involvement of alternative transcription factors, because STAT6 and c-Maf are known to be involved in gene expression of these cytokines [21] [22] [23] . It is, therefore, possible that inhibitory effect of Rb 1 on cytokine expression may be at least partially mediated through suppression of the NFAT transcription factor.
In summary, the application of ginsenoside Rb 1 was found to inhibit the development of AD-like skin lesions induced by DNCB. In addition, the results of the present study demonstrate that Rb 1 is capable of inhibiting the expression of cytokines, which results from the suppression of NFAT activation in splenocytes. Thus, Rb 1 is proposed as an effective new anti-inflammatory agent that may have a potential therapeutic use for preventing the advancement of atopic dermatitis. 
